3-(5-Substituted 2-Methoxyphenyl)-4-Nitro-2-Phenyl-5-Thiophene-2-yl-Isoxazolidines - Synthesis and Conformational Studies

Abstract

The synthesis of a new set of 2,3,4,5-substituted isoxazolidines having a sulfur containing heterocyclic moiety has been described. The structural features of the compounds have been analyzed by ¹H and ¹³C NMR spectroscopy as well as by single crystal X-ray studies.

[Supplemental materials are available for this article. Go to the publisher's online edition of Phosphorus, Sulfur, and Silicon and the Related Elements for the following free supplemental resource: .cif file.]     

Palladium(II)‐Catalyzed Synthesis of Isoxazolidines: Using a Catalytic Copper Acetate and Molecular Oxygen as the Cooxidant

An environmentally friendly process is reported for the palladium(II)‐catalyzed cyclofunctionalization of allylic hydroxylamine derivatives using a catalytic amount of copper(II) acetate and molecular oxygen as the cooxidant.     

苯炔与硝酮[3+2]环加成制备二取代苯并异噁唑烷

采用[3 2]1,3-偶极环加成反应,苯炔前体邻-三甲硅基苯酚三氟甲磺酸酯在氟化铯的作用下与硝酮反应合成了9个2,3-二取代苯并[d]异噁唑烷,收率87%～97%。其结构经1H NMR,13C NMR和高分辨率MS确证。     

Reduction of chromano–piperidine-fused isoxazolidines: Tandem intramolecular rearrangements leading to 2-(methylamino)-4-oxo-N-phenyl-N-propyl-4H-chromene-3-carboxamide

Reductive ring opening of isoxazolidine moiety of chromano–piperidine-fused isoxazolidines (3a–c) with HCOONH₄ and 10% Pd/C in a mixture of solvents (THF/MeOH) at ambient temperature, affords novel 2-(methylamino)-4-oxo-N-phenyl-N-propyl-4H-chromene-3-carboxamide (4), which is apparently derived from reductive NO bond cleavage followed by tandem intramolecular rearrangements. Plausible mechanistic rationale for the formation of compound 4 is proffered.     

Synthesis and Evaluation of Novel 5‐cyclohexyl‐2‐(4″‐substitutedphenyl)‐3‐(2″‐substitutedphenyl)4H‐2,3,3a,5,6,6a‐hexahydropyrrolo[3,4‐d]isoxazole‐4,6‐dione Derivatives for Their In Vitro Antioxidant and Antibacterial Activities

1,3‐Dipolar cycloaddition reactions of N‐cyclohexyl maleimide ( 1 ) with azomethine N‐oxide ( 2 ) have afforded novel isoxazolidine ( 3 ) in excellent yield. Their structures have been characterized from their IR, ¹H‐NMR, ¹³C‐NMR, ¹H,¹H‐COSY, MS(ESI), and elemental analysis techniques. In vitro antibacterial activity of the synthesized compounds were investigated against a representative panel of pathogenic strains specifically two Gram‐positive bacteria (Staphylococcus aureus and Streptococcus pyogenes ) and two Gram‐negative bacteria (Pseudomonas aeruginosa and Escherichia coli ) using agar‐well diffusion assay. Some of the compounds ( 3a , 3k , 3n , and 3o ) exhibited promising antibacterial activities. All the synthesized compounds have also been screened for their antioxidant activities and were found to be significantly active.     

Crystal structure of two brom containing aza-tetracyclic fused-ring N-heterocycles including isoxazolidine ring

Crystal structure of two brom containing aza-tetracyclic fused N-heterocycles including isoxazolidine ring compounds have been determined in single-crystal X-ray diffraction studies. The compound, C₁₄H₁₉BrN₂O₃, (1), and C₁₂H₁₅BrN₂O₃, (2), were obtained from a stereospecific[3+2] 1,3-cycloaddition of oxime based tandem nitrone generation reactions. The envelope conformation of the isoxazolidine rings are different, leading the substituents to be pseudoaxial in (1) and pseudoequatorial in (2). The stereochemistry of these fused compounds are exo- and endo-stereoisomer geometry contributed by exo and endo transition state of nitrone 1,3-dipolar cycloaddition reactions. The title compound (1) crystallizes in the monoclinic space group P2 ₁/n with a = 12.6221(5)Å, b = 7.5917(4) Å, c = 16.2350(9) Å, = 112.254(5)°, V = 1439.81(12) ų, and D _calc = 1.583 Mg/m³ for Z = 4 and compound (2) crystallizes in the monoclinic space group P2 ₁/c with a = 11.6906(9) Å, b = 6.4255(7) Å, c = 17.2070(10) Å, = 109.264(5)°, V = 1220.2(2) ų, and D _calc = 1.716 Mg/m³ for Z = 4. The antibacterial activity of both compounds were investigated for three Gram (+) and two Gram (–) bacteria by employing broth microdilution method and subsequently inhibitory activity against yeast-like fungi was also determined.     

endo-Selective (3+2) cycloaddition polymerizations of nitrone monomers with olefins utilising high pressure conditions

A high pressure mediated (3+2) cycloaddition polymerization strategy has been employed to afford linear poly(isoxazolidine) architectures. Under these high pressure conditions this cycloaddition process was found to afford primarily endo-heterocycles which when translated to the polymerization should ultimately affect the tacticity and resultant properties of the polymer. The stereoselectivity occurred as a result of a lower volume of activation for the endo-transition state and the application of a ‘type-I’ regime (HOMO_Dipole-LUMO_{Dipolarophile}) cycloaddition process that features secondary orbital interactions within the extended molecular orbitals. A variety of linker segments were employed in an attempt to affect the physical properties of the polymeric cycloadducts such as T_g and solubility in order to tailor these materials for use in coating applications.     

SYNTHESIS OF C-LINKED SUGAR BUTENOLIDES AND THEIR CONVERSION INTO C-LINKED ISOXAZOLIDINE SACCHARIDES *

Synthesis of C-linked isoxazolidines was achieved by addition of nitrone to C-linked sugar butenolides, which in turn were prepared by iodolactonisation on the chiral template derived from diacetone glucose.     

Microwave‐Assisted Stereoselective 1,3‐Dipolar Cycloaddition of C,N‐Diarylnitrone (i.e., N‐(Arylmethylidene)benzenamine N‐Oxide) and Bis(arylmethylidene)acetone (=1,5‐Diarylpenta‐1,4‐dien‐3‐one): NMR and Crystal Analysis of Diastereoisomeric Bis(isoxazolidines)

Microwave‐assisted stereoselective 1,3‐dipolar cycloaddition of C,N‐diarylnitrones (i.e., N‐(arylmethylidene)benzenamine N‐oxides) 2 to substituted bis(arylmethylidene)acetones (=1,5‐diarylpenta‐1,4‐dien‐3‐ones) 1 leading to diastereoisomer pairs of bis‐isoxazolidines 3 and 4 in good to excellent yield is described (Scheme 2 and Table 2). The configuration outcome of the reaction is discussed based on the NMR and X‐ray data of the products.     

Synthesis, Crystal and Molecular Structure and Biological Activity of Dimethyl Trans-3-（2- bromophenyl）-2-methylisoxazolidine-4,5-dicarboxylate

The compound of dimethyl trans-3-(2-bromophenyl)-2-methylisoxazolidine-4,5-dicarboxylate has been synthesized and characterized by IR, 1H-NMR, 13C-NMR, 2D-NMR (COSY, NOESY, HMQC, HMBC) and UV-vis. spectroscopy techniques and single-crystal X-ray diffraction (XRD). The biological activities of the title compound have been investigated in detail. The new compound crystallizes in monoclinic, space group C2/c with a = 26.9263(10), b = 7.0970(2), c = 19.8554(7) ?, and β = 126.630(2). In addition to the single crystal structure, the molecular geometry, vibrational frequencies, chemical shifts, molecular electrostatic potential and frontier molecular orbital analysis of the title compound in the ground state have been calculated by Density Functional Theory (DFT) method.